Document is current
Any future updates will be listed below
-
Authors
Hatano, Mai
Nakajima, Waki
Tani, Hideaki
Uchida, Hiroyuki https://orcid.org/0000-0002-0628-7036
Miyazaki, Tomoyuki
Arisawa, Tetsu
Takada, Yuuki
Tsugawa, Sakiko
Sano, Akane
Nakano, Kotaro
Eiro, Tsuyoshi
Abe, Hiroki
Suda, Akira
Asami, Takeshi
Hishimoto, Akitoyo
Nagai, Nobuhiro
Koizumi, Teruki
Nakajima, Shinichiro https://orcid.org/0000-0002-2601-2195
Kurokawa, Shunya https://orcid.org/0000-0001-6451-5263
Ohtani, Yohei
Takahashi, Kie
Kikuchi, Yuhei https://orcid.org/0000-0003-4656-5763
Yatomi, Taisuke
Honda, Shiori
Jinzaki, Masahiro
Hirano, Yoji https://orcid.org/0000-0001-6847-9677
Mitoma, Ryo
Tamura, Shunsuke
Baba, Shingo
Togao, Osamu
Kosaka, Hirotaka https://orcid.org/0000-0003-2210-5025
Okazawa, Hidehiko https://orcid.org/0000-0001-7046-3383
Kimura, Yuichi
Mimura, Masaru
Takahashi, Takuya https://orcid.org/0000-0001-6523-0622
- License Information
-
More Information
Article History
Received: 28 February 2024
Revised: 4 October 2024
Accepted: 7 October 2024
First Online: 15 October 2024
Competing interests
: TT and TM are the inventors of a patent application for a novel compound that specifically binds to the AMPA receptor (WO 2017006931), including [11C]K-2. TT, TM and TA are the founders and also stockholders of AMPAMETRY, Inc., which holds the exclusive license to use [11C]K-2. No other potential conflicts of interest relevant to this article exist.
